Microbix Biosystems Inc. (MBXBF)
OTCMKTS · Delayed Price · Currency is USD
0.1800
+0.0015 (0.84%)
Aug 15, 2025, 3:35 PM EDT
Microbix Biosystems Cash Flow Statement
Financials in millions CAD. Fiscal year is October - September.
Millions CAD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | 2016 - 2020 |
Net Income | -0.32 | 3.52 | -0.04 | 1.79 | 3.23 | -6.23 | Upgrade |
Depreciation & Amortization | 1.46 | 1.47 | 1.02 | 0.9 | 0.68 | 0.55 | Upgrade |
Other Amortization | 0.24 | 0.14 | 0.14 | 0.14 | 0.14 | 0.14 | Upgrade |
Loss (Gain) From Sale of Assets | -0.17 | -0.17 | - | - | - | - | Upgrade |
Asset Writedown & Restructuring Costs | - | - | -3.08 | - | - | 3.08 | Upgrade |
Stock-Based Compensation | 0.63 | 0.71 | 0.74 | 0.65 | 0.38 | 0.16 | Upgrade |
Other Operating Activities | 0.66 | 0.44 | 0.35 | 0.33 | 0.89 | 1.85 | Upgrade |
Change in Accounts Receivable | 1.65 | -0.04 | -1.06 | 1.12 | -2.3 | -0.17 | Upgrade |
Change in Inventory | -2.61 | -0.71 | -0.47 | -0.88 | -0.11 | 0.19 | Upgrade |
Change in Accounts Payable | -0.46 | 0.39 | 0.25 | -0.22 | 0.18 | 0.02 | Upgrade |
Change in Unearned Revenue | -0.55 | -1.56 | 1.22 | -0.31 | -0.69 | 0.49 | Upgrade |
Change in Other Net Operating Assets | 0.04 | 0.12 | -0.14 | -0.05 | -0.27 | -0.12 | Upgrade |
Operating Cash Flow | 0.6 | 4.35 | -1.09 | 3.47 | 2.11 | 0.01 | Upgrade |
Operating Cash Flow Growth | -71.69% | - | - | 64.48% | 24494.16% | -80.69% | Upgrade |
Capital Expenditures | -0.87 | -1.64 | -1.02 | -2.03 | -1.24 | -0.81 | Upgrade |
Sale (Purchase) of Intangibles | - | -0.27 | - | - | -0.06 | -0 | Upgrade |
Other Investing Activities | - | - | - | - | 0.68 | - | Upgrade |
Investing Cash Flow | -0.87 | -1.91 | -1.02 | -2.03 | -0.62 | -0.81 | Upgrade |
Long-Term Debt Issued | - | - | 1.54 | 1.07 | 0.63 | 0.74 | Upgrade |
Total Debt Issued | - | - | 1.54 | 1.07 | 0.63 | 0.74 | Upgrade |
Long-Term Debt Repaid | - | -0.52 | -0.3 | -2.45 | -0.55 | -2.09 | Upgrade |
Total Debt Repaid | -1.42 | -0.52 | -0.3 | -2.45 | -0.55 | -2.09 | Upgrade |
Net Debt Issued (Repaid) | -1.42 | -0.52 | 1.24 | -1.38 | 0.08 | -1.35 | Upgrade |
Issuance of Common Stock | 2.82 | 0.36 | 0.11 | 3.44 | 9.09 | 2.36 | Upgrade |
Repurchase of Common Stock | -1.84 | -0.93 | -1.12 | - | - | - | Upgrade |
Other Financing Activities | -0 | - | - | - | -0.77 | -0.21 | Upgrade |
Financing Cash Flow | -0.44 | -1.08 | 0.23 | 2.06 | 8.41 | 0.8 | Upgrade |
Miscellaneous Cash Flow Adjustments | -0 | - | - | - | - | - | Upgrade |
Net Cash Flow | -0.71 | 1.36 | -1.88 | 3.5 | 9.89 | -0 | Upgrade |
Free Cash Flow | -0.27 | 2.71 | -2.11 | 1.44 | 0.86 | -0.8 | Upgrade |
Free Cash Flow Growth | - | - | - | 66.64% | - | - | Upgrade |
Free Cash Flow Margin | -1.28% | 10.68% | -12.78% | 7.55% | 4.65% | -7.64% | Upgrade |
Free Cash Flow Per Share | -0.00 | 0.02 | -0.01 | 0.01 | 0.01 | -0.01 | Upgrade |
Levered Free Cash Flow | -0.74 | 0.75 | -1.43 | 0.81 | -1.06 | -0.3 | Upgrade |
Unlevered Free Cash Flow | -0.16 | 1.33 | -0.91 | 1.33 | -0.05 | 0.36 | Upgrade |
Change in Working Capital | -1.9 | -1.77 | -0.22 | -0.34 | -3.22 | 0.46 | Upgrade |
Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.